Sign in to download the Issue in PDF format.
1Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece
2Institute of Epidemiology, Preventive Medicine and Public Health, Corfu, Greece
AI Venetsanopoulou
, Y Alamanos, PV Voulgari, AA Drosos
1. Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers 2018;4:18001.
2. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol 1998;27 Suppl 1:S18-24.
3. Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert Rev Clin Immunol 2022;18(9):923-931.
4. Oliver JE, Silman AJ. What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases. Arthritis Res Ther 2009;11(3):223.
5. van Delft MAM, Huizinga TWJ. An overview of autoantibodies in rheumatoid arthritis. J Autoimmun 2020;110:102392.
6. Ajeganova S, Huizinga TW. Rheumatoid arthritis: Seronegative and seropositive RA: alike but different? Nat Rev Rheumatol 2015;11(1):8-9.
7. Wasserman A. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. Am Fam Physician 2018;97(7):455-462.
8. Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA 2018;320(13):1360-72.
9. Drosos AA, Pelechas E, Kaltsonoudis E, Voulgari PV. Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment. Curr Rheumatol Rep 2020;22(8):44.
10. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569-81.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315-24.
12. Berglin E, Dahlqvist SR. Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study. Scand J Rheumatol 2013;42(5):362-8.
13. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11(3):229.
14. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 1997;27(2):123-40.
15. Ali-Gombe A, Adebajo A, Silman A. Methodological problems in comparing the severity of rheumatoid arthritis between populations. Br J Rheumatol 1995;34(8):781-4.
16. Mijiyawa M. Epidemiology and semiology of rheumatoid arthritis in Third World countries. Rev Rhum Engl Ed 1995;62(2):121-6.
17. MacGregor AJ, Silman AJ. A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. J Rheumatol 1992;19(8):1163-5.
18. Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 2019;78(11):1463-71.
19. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006;36(3):182-8.
20. Australian Institute of Health and Welfare. Rheumatoid Arthritis. Australian Institution of Health and Welfare. https ://www.aihw.gov.au/reports/arthritis-other-musculoskeletal-conditions/rheumatoid-arthritis/contents/who-gets-rheumatoid-arthritis, Accessed 30 Aug 2019.
21. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989;129(6):1170-8.
22. Harvey J, Lotze M, Stevens MB, Lambert G, Jacobson D. Rheumatoid arthritis in a Chippewa Band. I. Pilot screening study of disease prevalence. Arthritis Rheum 1981;24(5):717-21.
23. Brighton SW, de la Harpe AL, van Staden DJ, Badenhorst JH, Myers OL. The prevalence of rheumatoid arthritis in a rural African population. J Rheumatol 1988;15(3):405-8.
24. Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC, et al. Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 1993;20(4):618-22.
25. Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis. PLoS One 2015;10(8):e0133858.
26. Silman AJ, Hochberg MC. Epidemiology of the rheumatic diseases. Oxford: Oxford University Press, 1993.
27. Hochberg MC. Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin Arthritis Rheum 1990;19(5):294-302.
28. Venetsanopoulou AI, Alamanos Y, Skalkou A, Voulgari PV, Drosos AA. The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre. Scand J Rheumatol 2022;12:1-8.
29. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111(1):87-98.
30. Dugowson CE, Koepsell TD, Voigt LF, Bley L, Nelson JL, Daling JR. Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum 1991;34(12):1502-7.
31. Jacobsson LT, Hanson RL, Knowler WC, Pillemer S, Pettitt DJ, McCance DR, et al. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum 1994;37(8):1158-65.
32. Spector TD, Hart DJ, Powell RJ. Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence for a secular decline. Ann Rheum Dis 1993;52(4):254-7.
33. Adebajo AO. Rheumatoid arthritis: a twentieth century disease in Africa? Arthritis Rheum 1991;34(2):248-9.
34. van den Hoek J, Boshuizen HC, Roorda LD, Tijhuis GJ, Nurmohamed MT, van den Bos GA, et al. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 2017;37(4):487-93.
35. Gordon P, West J, Jones H, Gibson T. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. J Rheumatol 2001;28(11):2409-15.
36. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26(12):2529-33.
37. Listing J, Kekow J, Manger B, Burmester GR, Pattloch D, Zink A, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis 2015;74(2):415-21.
38. Bournia VK, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, Vourli G, Paraskevis D, Tektonidou MG, Sfikakis PP. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019. RMD Open 2021 Nov;7(3):e001694.
39.Dadoun S, Zeboulon-Ktorza N, Combescure C, Elhai M, Rozenberg S, Gossec L, Fautrel B. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 2013;80(1):29-33.
40. Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts. http://acrabstracts.org/abstract/reduced-mortality-risk-in-rheumatoid-arthritis-findings-from-two-uk-inception-cohorts.
41. Provan SA, Lillegraven S, Sexton J, Angel K, Austad C, Haavardsholm EA, et al. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology (Oxford) 2020;59(3):505-12.
42. Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis 2017;76(6):1057-63.
43. http://acrabstracts.org/abstract/mortality-trends-in-rheumatoid-arthritis-during-the-biologic-era-1998-to-2011/ [accessed 23.02.16].
44. Molina E, del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates. BMC Musculoskelet Disord 2015;16:277.
45. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K,et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43(1):30-7.
46. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, et al . Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 2012;44(5):483-9.
47. Padyukov L, Seielstad M, Ong RT, Ding B, Rönnelid J, Seddighzadeh M,et al; Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study group. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011;70(2):259-65.
48. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010;22(3):293-8.
49. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002;31(6):355-60.
50. Ding B, Padyukov L, Lundström E, Seielstad M, Plenge RM, Oksenberg JR, et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009;60(1):30-8.
51. Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): Updated systematic review and meta-analysis. J Gene Med 2020;22(9):e3204.
52. Zhou C, Gao S, Yuan X, Shu Z, Li S, Sun X, et al. Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: a meta-analysis. Aging (Albany NY) 2021;13(15):19397-414.
53. Chang X, Xia Y, Pan J, Meng Q, Zhao Y, Yan X. PADI2 is significantly associated with rheumatoid arthritis. PLoS One 2013;8(12):e81259.
54. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;35(7):749-55.
55. Tikly M, Govind N, Frost J, Ramsay M. The PTPN22 R620W polymorphism is not associated with systemic rheumatic diseases in South Africans. Rheumatology (Oxford) 2010;49(4):820-1.
56. Nemtsova MV, Zaletaev DV, Bure IV, Mikhaylenko DS, Kuznetsova EB, Alekseeva EA, et al. Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis. Front Genet 2019;10:570.
57. Carubbi F, Alunno A, Gerli R, Giacomelli R. Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis. Cells 2019;8(7):657.
58. Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 2006;1069:212-22.
59. van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye.. BMC Med 2009;7:12.
60. Raine C, Giles I. What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis? Front Med (Lausanne) 2022;9:909879.
61. Zhang X, Qiao P, Guo Q, Liang Z, Pan J, Wu F, et al. High Follicle-Stimulating Hormone Level Associated With Risk of Rheumatoid Arthritis and Disease Activity. Front Endocrinol (Lausanne) 2022;13:862849.
62. Chen H, Wang J, Zhou W, Yin H, Wang M. Breastfeeding and Risk of Rheumatoid Arthritis: A Systematic Review and Metaanalysis. J Rheumatol 2015;42(9):1563-9.
63. Doran MF, Crowson CS, O'Fallon WM, Gabriel SE. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004;31(2):207-13.
64. Elsayed, S.A., Henry, D.M. & Abu Elfadl, E.M. Impact of oral contraceptives and breastfeeding on disease activity in a sample of Egyptian rheumatoid arthritis patients. Egypt Rheumatol Rehabil 2020;47:46.
65. Chen Q, Jin Z, Xiang C, Cai Q, Shi W, He J. Absence of protective effect of oral contraceptive use on the development of rheumatoid arthritis: a meta-analysis of observational studies. Int J Rheum Dis 2014;17(7):725-37.
66. Eun Y, Jeon KH, Han K, Kim D, Kim H, Lee J, et al. Menopausal factors and risk of seropositive rheumatoid arthritis in postmenopausal women: a nationwide cohort study of 1.36 million women. Sci Rep 2020;10(1):20793.
67. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009;155(1):1-15.
68. Ball RJ, Avenell A, Aucott L, Hanlon P, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis. Arthritis Res Ther 2015;17:274.
69. Kudaeva FM, Speechley MR, Pope JE. A systematic review of viral exposures as a risk for rheumatoid arthritis. Semin Arthritis Rheum 2019;48(4):587-96.
70. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, van der Bijl AE, Venhuizen AC, Huizinga TWJ, et al. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis 2021;80(8):1096-98.
71. Drosos AA, Pelechas E, Voulgari PV. Seronegative Erosive Arthritis Following SARS-CoV-2 Infection. Rheumatol Ther 2022;9(1):295-301.
72. Perricone C, Ceccarelli F, Saccucci M, Di Carlo G, Bogdanos DP, Lucchetti R, et al. Porphyromonas gingivalis and rheumatoid arthritis. Curr Opin Rheumatol 2019;31(5):517-524.
73. Kaur S, White S, Bartold M. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review. JBI Libr Syst Rev 2012;10(42 Suppl):1-12.
74. Li S, Yu Y, Yue Y, Zhang Z, Su K. Microbial Infection and Rheumatoid Arthritis. J Clin Cell Immunol 2013;4(6):174.
75. Carlens C, Jacobsson L, Brandt L, Cnattingius S, Stephansson O, Askling J. Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 2009;68(7):1159-64.
76. Colebatch AN, Edwards CJ. The influence of early life factors on the risk of developing rheumatoid arthritis. Clin Exp Immunol 2011;163(1):11-6.
77. Calixto OJ, Anaya JM. Socioeconomic status. The relationship with health and autoimmune diseases. Autoimmun Rev 2014;13(6):641-54.
78. Verstappen SMM. The impact of socio-economic status in rheumatoid arthritis. Rheumatology (Oxford) 2017;56(7):1051-2.
79. Yang DH, Huang JY, Chiou JY, Wei JC. Analysis of Socioeconomic Status in the Patients with Rheumatoid Arthritis. Int J Environ Res Public Health 2018;15(6):1194.
80. Kerola AM, Sexton J, Wibetoe G, Rollefstad S, Crowson CS, Mars N, et al. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Semin Arthritis Rheum 2021 Oct;51(5):1081-8.
81. Cho SK, Kim D, Won S, Lee J, Choi CB, Choe JY, et al. Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis. Korean J Intern Med 2019;34(4):910-6.
82. Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E. Environmental and Health Impacts of Air Pollution: A Review. Front Public Health 2020;8:14.
83. Zhao CN, Xu Z, Wu GC, Mao YM, Liu LN, Qian-Wu, et al. Emerging role of air pollution in autoimmune diseases. Autoimmun Rev 2019;18(6):607-4.
84. Sigaux J, Biton J, André E, Semerano L, Boissier MC. Air pollution as a determinant of rheumatoid arthritis. Joint Bone Spine 2019;86(1):37-42.
85. Alsaber A, Pan J, Al-Herz A, Alkandary DS, Al-Hurban A, Setiya P; On Behalf Of The Krrd Group. Influence of Ambient Air Pollution on Rheumatoid Arthritis Disease Activity Score Index. Int J Environ Res Public Health 2020;17(2):416.
86. Hart JE, Laden F, Puett RC, Costenbader KH, Karlson EW. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect 2009;117(7):1065-9.
87. Chang KH, Hsu CC, Muo CH, Hsu CY, Liu HC, Kao CH, et al. Air pollution exposure increases the risk of rheumatoid arthritis: A longitudinal and nationwide study. Environ Int 2016;94:495-99.
88. Alex AM, Kunkel G, Sayles H, Flautero Arcos JD, Mikuls TR, Kerr GS. Exposure to ambient air pollution and autoantibody status in rheumatoid arthritis. Clin Rheumatol 2020;39(3):761-8.
89. Adami G, Viapiana O, Rossini M, Orsolini G, Bertoldo E, Giollo A, et al. Association between environmental air pollution and rheumatoid arthritis flares. Rheumatology (Oxford) 2021;60(10):4591-7.
90. Kauppinen T, Toikkanen J, Pedersen D, Young R, Ahrens W, Boffetta P, et al. Occupational exposure to carcinogens in the European Union. Occup Environ Med 2000;57(1):10-8.
91. Requena-Mullor M, Alarcón-Rodríguez R, Parrón-Carreño T, Martínez-López JJ, Lozano-Paniagua D, Hernández AF. Association between Crystalline Silica Dust Exposure and Silicosis Development in Artificial Stone Workers. Int J Environ Res Public Health 2021;18(11):5625.
92. Graff P, Larsson J, Bryngelsson IL, Wiebert P, Vihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case-control study. BMJ Open 2020;10(9):e038926.
93. Hnizdo E, Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med 2003;60(4):237-43.
94. Mehri F, Jenabi E, Bashirian S, Shahna FG, Khazaei S. The association Between Occupational Exposure to silica and Risk of Developing Rheumatoid Arthritis: A Meta-Analysis. Saf Health Work 2020;11(2):136-42.
95. Blanc PD, Järvholm B, Torén K. Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers. Am J Med 2015;128(10):1094-101.
96. Anlar HG, Bacanli M, İritaş S, Bal C, Kurt T, Tutkun E, et al. Effects of Occupational Silica Exposure on OXIDATIVE Stress and Immune System Parameters in Ceramic Workers in TURKEY. J Toxicol Environ Health A 2017;80(13-15):688-96.
97. Ilar A, Klareskog L, Saevarsdottir S, Wiebert P, Askling J, Gustavsson P, et al. Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study. RMD Open 2019;5(2):e000978.
98. Chang K, Yang SM, Kim SH, Han KH, Park SJ, Shin JI. Smoking and rheumatoid arthritis. Int J Mol Sci 2014;15(12):22279-95.
99. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006;119(6):503.e1-9.
100. Di Giuseppe D, Discacciati A, Orsini N, Wolk A. Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 2014;16(2):R61.
101. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50(10):3085-92.
102. Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006;45(6):734-40.
103. Hutchinson D, Moots R. Cigarette smoking and severity of rheumatoid arthritis. Rheumatology (Oxford) 2001;40(12):1426-7.
104. Torrente-Segarra V, Bergstra SA, Solomon-Escoto K, Da Silva J, Veale DJ, Al-Emadi S, et al. Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients? Scand J Rheumatol 2018;47(5):360-3.
105. Liu X, Tedeschi SK, Barbhaiya M, Leatherwood CL, Speyer CB, Lu B, et al. Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses' Health Studies. Arthritis Care Res (Hoboken) 2019;71(7):914-24.
106. Kotewar SS, Pakhale A, Tiwari R, Reche A, Singi SR. Electronic Nicotine Delivery System: End to Smoking or Just a New Fancy Cigarette. Cureus 2023 Aug 13;15:e43425.
107. Lu B, Solomon DH, Costenbader KH, Karlson EW. Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study. Arthritis Rheumatol 2014;66(8):1998-2005.
108. Di Giuseppe D, Alfredsson L, Bottai M, Askling J, Wolk A. Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study. BMJ 2012;345:e4230.
109. Scott IC, Tan R, Stahl D, Steer S, Lewis CM, Cope AP. The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013;52(5):856-67.
110. Jin Z, Xiang C, Cai Q, Wei X, He J. Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-analysis of prospective studies. Ann Rheum Dis 2014;73(11):1962-7.
111. Hedenstierna L, Bellocco R, Ye W, Adami HO, Åkerstedt T, Trolle Lagerros Y, et al. Effects of alcohol consumption and smoking on risk for RA: results from a Swedish prospective cohort study. RMD Open 2021;7(1):e001379.
112. Turk JN, Zahavi ER, Gorman AE, Murray K, Turk MA, Veale DJ. Exploring the effect of alcohol on disease activity and outcomes in rheumatoid arthritis through systematic review and meta-analysis. Sci Rep 2021;11(1):10474.
113. Hedström AK, Hössjer O, Klareskog L, Alfredsson L. Interplay between alcohol, smoking and HLA genes in RA aetiology. RMD Open 2019;5(1):e000893.
114. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179(3):1634-47.
115. Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 2012;31(12):1733-9.
116. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50(1):72-7.
117. Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee IM, Manson JE, Costenbader KH. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 2022 Jan 26;376:e066452.
118. Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32(1):1-22.
119. Bae SC, Lee YH. Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization. Clin Rheumatol 2018;37(9):2415-21.
120. Mazzucca CB, Raineri D, Cappellano G, Chiocchetti A. How to Tackle the Relationship between Autoimmune Diseases and Diet: Well Begun Is Half-Done. Nutrients 2021;13(11):3956.
121. Linos A, Kaklamanis E, Kontomerkos A, Koumantaki Y, Gazi S, Vaiopoulos G, et al. The effect of olive oil and fish consumption on rheumatoid arthritis--a case control study. Scand J Rheumatol 1991;20(6):419-26.
122. Forsyth C, Kouvari M, D'Cunha NM, Georgousopoulou EN, Panagiotakos DB, Mellor DD, et al. The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies. Rheumatol Int 2018;38(5):737-47.
123. Johansson K, Askling J, Alfredsson L, Di Giuseppe D; EIRA study group. Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study. Arthritis Res Ther 2018;20(1):175.
124. Pattison DJ, Symmons DP, Lunt M, Welch A, Luben R, Bingham SA, et al. Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004;50(12):3804-12.
125. Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep 2014;14(1):404.
126. Feng X, Xu X, Shi Y, Liu X, Liu H, Hou H, et al. Body Mass Index and the Risk of Rheumatoid Arthritis: An Updated Dose-Response Meta-Analysis. Biomed Res Int 2019; 2019:3579081.
127. Venetsanopoulou AI, Voulgari PV, Drosos AA. Fasting mimicking diets: A literature review of their impact on inflammatory arthritis. Mediterr J Rheumatol 2020;30(4):201-06.
128. Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z, Qin D. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front Immunol 2022 Sep 8;13:1007165.
129. Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era. Front Pharmacol 2021 Jul 23;12:711788.
130. Bae SC, Lee YH. Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study. Clin Rheumatol 2018;37(10):2875-9.
131. Schoenfeld SR, Lu L, Rai SK, Seeger JD, Zhang Y, Choi HK. Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2016;75(7):1315-20.
132. Li GM, Zhao J, Li B, Zhang XF, Ma JX, Ma XL, et al. The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials. Autoimmun Rev 2018;17(3):215-25.
133. Myasoedova E, Karmacharya P, Duarte-Garcia A, Davis JM 3rd, Murad MH, Crowson CS. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2020;50(6):1348-56.
